Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients

Int J Clin Pharmacol Ther. 2011 Jan;49(1):88-90.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Pyrroles / therapeutic use*
  • Sunitinib
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor Receptor-2 / analysis
  • Vascular Endothelial Growth Factor Receptor-3 / analysis

Substances

  • Biomarkers, Tumor
  • Indoles
  • Pyrroles
  • SU 12662
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-2
  • Vascular Endothelial Growth Factor Receptor-3
  • Sunitinib